{"id":6198,"date":"2026-02-20T17:09:04","date_gmt":"2026-02-20T17:09:04","guid":{"rendered":"https:\/\/oncopeptides.com.haus.se\/newsroom\/news\/oncopeptides-vd-sofia-heigis-intervjuad-av-redeye-om-q4-och-nyemissionen\/"},"modified":"2026-02-20T17:09:04","modified_gmt":"2026-02-20T17:09:04","slug":"oncopeptides-vd-sofia-heigis-intervjuad-av-redeye-om-q4-och-nyemissionen","status":"publish","type":"news","link":"https:\/\/oncopeptides.com.haus.se\/sv\/nyheter\/oncopeptides-vd-sofia-heigis-intervjuad-av-redeye-om-q4-och-nyemissionen\/","title":{"rendered":"Oncopeptides vd Sofia Heigis intervjuad av Redeye om Q4 och nyemissionen"},"content":{"rendered":"<p class=\"preamble\">Redeye-analytikern Richard Remanius intervjuade nyligen VD Sofia Heigis om det fj\u00e4rde kvartalet och den kommande nyemissionen p\u00e5 cirka 200 miljoner kronor. Intervjun h\u00e5lls p\u00e5 svenska. <\/p>\n<p>Se intervjun  <strong><a href=\"https:\/\/www.redeye.se\/research\/1152801\/oncopeptides-q4-intervju-redeye-pratar-med-vd-sofia-heigis?\" target=\"_blank\" rel=\"noopener noreferrer\">via denna l\u00e4nk<\/a><\/strong>  (kr\u00e4ver kostnadsfritt medlemskap hos Redeye).<\/p>\n","protected":false},"featured_media":5694,"template":"","meta":{"_acf_changed":false},"news_categories":[365],"protected-content":[],"class_list":["post-6198","news","type-news","status-publish","has-post-thumbnail","hentry","news_categories-investerare"],"acf":[],"_links":{"self":[{"href":"https:\/\/oncopeptides.com.haus.se\/sv\/wp-json\/wp\/v2\/news\/6198","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/oncopeptides.com.haus.se\/sv\/wp-json\/wp\/v2\/news"}],"about":[{"href":"https:\/\/oncopeptides.com.haus.se\/sv\/wp-json\/wp\/v2\/types\/news"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/oncopeptides.com.haus.se\/sv\/wp-json\/wp\/v2\/media\/5694"}],"wp:attachment":[{"href":"https:\/\/oncopeptides.com.haus.se\/sv\/wp-json\/wp\/v2\/media?parent=6198"}],"wp:term":[{"taxonomy":"news_categories","embeddable":true,"href":"https:\/\/oncopeptides.com.haus.se\/sv\/wp-json\/wp\/v2\/news_categories?post=6198"},{"taxonomy":"protected-content","embeddable":true,"href":"https:\/\/oncopeptides.com.haus.se\/sv\/wp-json\/wp\/v2\/protected-content?post=6198"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}